Senator Dick Durbin @SenatorDurbin
‘Product hopping’ is one of the many tricks Big Pharma uses to block competition and extort American patients & taxpayers, costing nearly $5B annually. It must be reined in. This report dives into the practice of ‘product hopping’ and just how harmful it can be. — PolitiTweet.org
CAPD @RxDrugCoalition
NEW: A report by @MGA_Health finds that just five examples of ‘product hopping’ by drug companies cost American pat… https://t.co/2YXsZPr3dU